MENU
AKTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aktis Oncology (AKTS) Ownership - Who owns Aktis Oncology?

Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies... Show more

Profile

Industry
Telecommunications Equipment
Address
17 Drydock Avenue
Phone
+1 617 461-4023
Employees
75
Web
https://www.aktisoncology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1B
P/E Ratio
N/A
Total Cash
538.48M
Projected Growth
N/A
Total Debt
11.58M
Revenue
8.28M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.74
Total Debt/Equity
N/A
Revenue/Share
0.15 USD as % of share price
View a ticker or compare two or three
AKTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of filter products for radio frequency front-ends for mobile wireless devices

Industry Biotechnology

Profile
Details
Industry
Telecommunications Equipment
Address
17 Drydock Avenue
Phone
+1 617 461-4023
Employees
75
Web
https://www.aktisoncology.com